Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment deteriorates as stock falls 26% After last week's 26% share price decline to ₹111, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 36% over the past year. New Risk • Mar 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹3.54b market cap, or US$38.4m). New Risk • Jan 20
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.4% average weekly change). High level of non-cash earnings (55% accrual ratio). Minor Risk Market cap is less than US$100m (₹3.06b market cap, or US$33.7m). Valuation Update With 7 Day Price Move • Dec 11
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹143, the stock trades at a trailing P/E ratio of 29.1x. Average trailing P/E is 23x in the Chemicals industry in India. New Risk • Nov 17
New major risk - Financial position The company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Market cap is less than US$100m (₹3.03b market cap, or US$34.2m). 공시 • Nov 14
Balaji Phosphates Limited to Report First Half, 2026 Results on Nov 14, 2025 Balaji Phosphates Limited announced that they will report first half, 2026 results on Nov 14, 2025 공시 • Sep 05
Balaji Phosphates Limited, Annual General Meeting, Sep 30, 2025 Balaji Phosphates Limited, Annual General Meeting, Sep 30, 2025, at 15:00 Indian Standard Time. Location: 305 utsav avenue, 12/5 usha ganj jaora compound, mp - 452001, indore India Valuation Update With 7 Day Price Move • Aug 21
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₹173, the stock trades at a trailing P/E ratio of 51.9x. Average trailing P/E is 27x in the Chemicals industry in India. Reported Earnings • Jul 09
Full year 2025 earnings released: EPS: ₹4.34 (vs ₹3.39 in FY 2024) Full year 2025 results: EPS: ₹4.34 (up from ₹3.39 in FY 2024). Revenue: ₹1.29b (down 15% from FY 2024). Net income: ₹79.2m (up 31% from FY 2024). Profit margin: 6.2% (up from 4.0% in FY 2024). The increase in margin was driven by lower expenses. Reported Earnings • Apr 03
First half 2025 earnings released First half 2025 results: EPS: ₹2.43. Net income: ₹43.4m (up ₹43.4m from 1H 2024). Valuation Update With 7 Day Price Move • Mar 25
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹91.10, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 25x in the Chemicals industry in India.